Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
OTC Markets
ETFs
Canadian ETFs
US ETFs
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Real Time & Level II Data
Showcase Companies
DealRoom
News Focus
Fokus Releases An Initial Mineral Resource Estimate On Galloway Gold Project (click to learn more)
TRILLION ENERGY ANNOUNCES 2022 YEAR END RESERVE REPORT (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Bright Minds Biosciences Inc Ordinary Shares
C.DRUG
Alternate Symbol(s):
BMBIF
Healthcare
Biotechnology
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain....
The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:DRUG)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(1)
•••
OTCLegenda
X
Post by
OTCLegenda
on Sep 19, 2022 1:51pm
There’s been a lot of buzz about psychedelic stocks lately
DRUG has actually kept the gains it made on its mid-August sympathy run. The psychedelic sector hasn’t caught fire like marijuana and biotechs have in the past couple years.
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Sep 07, 2022 6:50am
New Press Release - Bright Minds Biosciences Announces Appointment of Doug Williamson to Board of Directors
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATESVANCOUVER, British Columbia, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Bright Minds Biosciences (“Bright Minds,” “BMB” or the...
read article.
VERTEX RESOURCE GROUP REPORTS RECORD Q4 & YEAR END 2022 RESULTS
posted Mar 23, 2023 9:00am by
Vertex Resource Group Ltd.
-
|
Vertex achieved record quarterly net revenue of $59.8 million and record fourth quarter Adjusted EBITDA of $7.6 million, the highest of any fourth quarter in the Company's history. Record annual net revenue saw $218.4 million with a record annual Adjusted EBITDA o$32.2 million. The Company has experienced a steady demand for services from customers across multiple industries. The Company is ...read more
(433)
•••
AwareInvestor
X
Post by
AwareInvestor
on Aug 31, 2022 8:54am
Bright Minds Begins Phase 1 Clinical Trials Focused On Treat
Phase 1 trials are officially underway for Bright Minds Biosciences and their lead product, referred to as BMB-101. The firm this morning revealed that it has dosed the first patient under the trial
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Aug 31, 2022 6:50am
New Press Release - Bright Minds Biosciences Initiates Dosing in Phase I Clinical Trial of BMB-101 for Dravet Syndrome
In predictive animal models, BMB-101 demonstrated significant reduction in both the number and intensity of epileptic seizures VANCOUVER, British Columbia, Aug. 31, 2022 (GLOBE NEWSWIRE) -- Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Company”) (Nasdaq: DRUG) (CSE: DRUG), a...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Aug 30, 2022 3:35pm
New Press Release - Bright Minds Biosciences Announces Closing of $4 Million Unit Offering
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT AUTHORIZED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.VANCOUVER, British Columbia, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE:DRUG) (NASDAQ:DRUG) (...
read article.
(433)
•••
AwareInvestor
X
Post by
AwareInvestor
on Aug 24, 2022 8:41am
Bright Minds Biosciences Looks To Raise $4.0 Million Via Ove
After several days of intense volatility, Bright Minds Biosciences is looking to capitalize on the sudden investor interest. The firm has now announced terms for the pricing of its overnight marketed
...more
(56)
•••
cueball40
X
Post by
cueball40
on Aug 19, 2022 11:09am
im in
trying 5k here 2.17 area let her rip
(11)
•••
hashboy18
X
Post by
hashboy18
on Aug 18, 2022 1:08pm
shorts get smoked
they shorted it too low and got greedy,huge.ca is also short 6,2 million anson is feeling pain today
Thematica Insights Report and Investor Guide
Revolutionizing Energy
Innovations, Opportunities, and Challenges in the Shift to a Sustainable Future. Access the Report here.
Jocelyn Aspa
20 March 2023 17:31
(4)
•••
Whitman19
X
Post by
Whitman19
on Apr 13, 2022 2:52am
Upcoming catalysts
The next couple of catalysts include the toxicology study for 5HT2A to treat MDD/TRD and the Phase-1 clinical trials for BMB-101 to treat Alzheimer's. Both are likely to start this quarter
(4)
•••
Whitman19
X
Comment by
Whitman19
on Mar 25, 2022 2:59am
RE:Bright Minds Moves Into Clinical Development Stage Following
That's wonderful. Just waiting for the stock to take off
(433)
•••
AwareInvestor
X
Post by
AwareInvestor
on Mar 14, 2022 7:55am
Bright Minds Moves Into Clinical Development Stage Following
Drug development continues for the Bright Minds Biosciences lead product. The firm this morning published positive results from a recent 28-day toxicity study conducted on its novel formulation, BMB
...more
(4)
•••
Whitman19
X
Post by
Whitman19
on Jan 10, 2022 2:33am
BMB-101 is all set to hit the clinic in H1’22
Unlike most biotechs developing drugs from naturally occurring psychedelics, Bright Minds is creating novel compounds that retain the therapeutic benefits of psychedelics while minimising side effects
...more
(4)
•••
Whitman19
X
Post by
Whitman19
on Dec 29, 2021 11:23am
THE MOST POTENT NOVEL PSYCHEDELICS EVER CREATED...
"I would say we have the largest and most advanced psychedelic drug discovery program in the history of the world. That’s over 25 chemists working around the clock developing completely novel
...more
(4)
•••
Whitman19
X
Post by
Whitman19
on Dec 02, 2021 1:16am
BMB: The next-gen psychedelics to treat neuro conditions
Bright Minds has a portfolio of three patented mechanisms based on serotonin (5-HT) receptors, assessed for indications ranging from depression to chronic pain. The firm also has "
...more
(4)
•••
Whitman19
X
Comment by
Whitman19
on Nov 03, 2021 10:15am
RE:Bright Minds Bioscience Approved For Nasdaq Listing
This is one of the best news for the psychedelic sector in a long time...Way to go BM
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Herald Price Sensitive
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}}
{{story.headline}}
< Previous bulletin
Next bulletin >
The Power Play by The Market Herald
{{currentVideo.videoCaption}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous Video
{{moreVideoText}}
Next Video >
Featured News Links
This Junior Oil and Gas Company Listing soon on NYSE
Brascan (C.BRAS) Reports on New Critical Minerals Discovery in Newfoundland and Announces Private Placement
What Does the Future of Energy Look Like? – Report Available NOW
This Mineral Explorer Announces Geochem Survey - Identifies Additional Anomalies
ION Energy With Progress on their Lithium Brine Project - Completion of Third Water Well